Analysis of haemolysis-based injury in immortalised proximal tubule epithelial cells is impaired by haemoglobin interference with bioluminescence assays.
- 1University of Liverpool
Abstract
Acute kidney injury (AKI) is a serious complication which is common amongst cardiac and aortic/vascular surgery patients. Although the cause of AKI following cardiac surgery is multifactorial, haemolysis is an increasingly recognised contributing factor caused by the use of cardiopulmonary bypass machines. Haemolysis, the lysis of red blood cells, releases free haemoglobin (fHb) into the bloodstream which is known to cause kidney injury. Currently, the mechanisms of haemolysis-induced kidney injury are not fully understood. In this study, we investigated the injury response to fHb in a human-derived conditionally immortalised proximal tubule epithelial cell line (ciPTECs). Results showed that fHb interference reduces bioluminescence signal output which is considerably mitigated by removing fHb solutions and haemolysed plasma prior to the beginning of the assay. Interestingly, we found that the effect of fHb on ciPTECs was different with haemolysed plasma compared to fHb solutions, potentially due to factors other than fHb within the plasma. In contrast to expectations, haemolysed plasma induced only a marginal increase in NF-B activity and had minimal effect on mitochondrial function. Together, these findings suggest that caution should be applied when using bioluminescent assays with fHb, both in solution and haemolysed plasma, and that fHb may not inflict severe injury on ciPTECs.
Related
- Stage 3 acute kidney injury secondary to haemolysis after high-burden pulsed field ablation in a patient with normal baseline renal function: a case report
- Agreement Between Venous and Capillary Haemoglobin Concentrations in a High-Burden Urban Indian Setting: A Cross-Sectional Analysis
- Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus
- Anaemia in pregnancy in Bangladesh by the WHO 2024 haemoglobin cut-offs: a national biomarker survey and comparison with 2011
- Interval colorectal cancer risk by haemoglobin concentration in Australia's National Bowel Cancer Screening Program
BibTeX
@misc{trott2026analysis,
title = {{Analysis of haemolysis-based injury in immortalised proximal tubule epithelial cells is impaired by haemoglobin interference with bioluminescence assays.}},
author = {C. Trott and J. Bennett and P. A. Murray and A. Chadwick and S. J. McWilliam and B. Wilm},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.06.764891},
url = {https://www.biorxiv.org/content/10.64898/2026.11.06.764891v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Analysis of haemolysis-based injury in immortalised proximal tubule epithelial cells is impaired by haemoglobin interference with bioluminescence assays.
AU - C. Trott
AU - J. Bennett
AU - P. A. Murray
AU - A. Chadwick
AU - S. J. McWilliam
AU - B. Wilm
PY - 2026
DA - 2026/11/06
PB - bioRxiv
DO - 10.64898/2026.11.06.764891
UR - https://www.biorxiv.org/content/10.64898/2026.11.06.764891v1
AB - Acute kidney injury (AKI) is a serious complication which is common amongst cardiac and aortic/vascular surgery patients. Although the cause of AKI following cardiac surgery is multifactorial, haemolysis is an increasingly recognised contributing factor caused by the use of cardiopulmonary bypass machines. Haemolysis, the lysis of red blood cells, releases free haemoglobin (fHb) into the bloodstream which is known to cause kidney injury. Currently, the mechanisms of haemolysis-induced kidney injury are not fully understood. In this study, we investigated the injury response to fHb in a human-derived conditionally immortalised proximal tubule epithelial cell line (ciPTECs). Results showed that fHb interference reduces bioluminescence signal output which is considerably mitigated by removing fHb solutions and haemolysed plasma prior to the beginning of the assay. Interestingly, we found that the effect of fHb on ciPTECs was different with haemolysed plasma compared to fHb solutions, potentially due to factors other than fHb within the plasma. In contrast to expectations, haemolysed plasma induced only a marginal increase in NF-B activity and had minimal effect on mitochondrial function. Together, these findings suggest that caution should be applied when using bioluminescent assays with fHb, both in solution and haemolysed plasma, and that fHb may not inflict severe injury on ciPTECs.
ER -